Login / Signup

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.

Fernando PereiraAngel SerranoIsrael ManzanedoEstibalitz Pérez-ViejoSantiago González-MorenoLuis González-BayónAlvaro Arjona-SánchezJuan TorresIsabel RamosMaria E BarriosPedro CascalesRafael MoralesEnrique BoldóAlfonso García-FadriqueXabier ArteagaAlberto Gutierrez-CalvoSusana Sánchez-GarcíaEnrique AsensioCesar P RamírezManuel ArtilesJavier VaquéPedro A ParraPedro VillarejoCristóbal Muñoz-CasaresEstrella TurienzoAlicia CaleroIsabel Jaén TorrejimenoIsabel PrietoJulio GalindoVicente BorregoManuel E MarcelloCristina RihueteJoaquin CarrascoLuis Gomez-Quiles
Published in: BMC cancer (2022)
EudraCT number: 2019-004679-37; Clinicaltrials.gov: NCT05250648 (registration date 02/22/2022, ).
Keyphrases
  • locally advanced
  • double blind
  • radiation therapy
  • clinical trial